Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy.

Hilz MJ, Brys M, Marthol H, Stemper B, Dütsch M.

Neurology. 2004 Apr 13;62(7):1066-72.

PMID:
15079003
2.

Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy.

Schiffmann R.

Acta Neurol Belg. 2006 Jun;106(2):61-5. Review.

PMID:
16898255
3.

Fabry disease.

Toyooka K.

Handb Clin Neurol. 2013;115:629-42. doi: 10.1016/B978-0-444-52902-2.00037-0. Review.

PMID:
23931807
4.

Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.

Mignani R, Feriozzi S, Schaefer RM, Breunig F, Oliveira JP, Ruggenenti P, Sunder-Plassmann G.

Clin J Am Soc Nephrol. 2010 Feb;5(2):379-85. doi: 10.2215/CJN.05570809. Epub 2010 Jan 7. Review.

5.

Fabry disease.

Toyooka K.

Curr Opin Neurol. 2011 Oct;24(5):463-8. doi: 10.1097/WCO.0b013e32834a9433. Review.

PMID:
21825987
6.

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR.

Ann Intern Med. 2003 Feb 18;138(4):338-46. Review.

PMID:
12585833
7.

Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.

Breunig F, Wanner C.

J Nephrol. 2008 Jan-Feb;21(1):32-7. Review.

PMID:
18264934
8.

Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.

Bersano A, Lanfranconi S, Valcarenghi C, Bresolin N, Micieli G, Baron P.

Acta Neurol Scand. 2012 Aug;126(2):77-97. doi: 10.1111/j.1600-0404.2012.01661.x. Epub 2012 Mar 19. Review.

PMID:
22428782
9.

The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature.

Bekri S, Lidove O, Jaussaud R, Knebelmann B, Barbey F.

Cardiovasc Hematol Agents Med Chem. 2006 Oct;4(4):289-97. Review.

PMID:
17073606
10.

Laser evoked potentials for assessing sensory neuropathy in human patients.

Truini A, Romaniello A, Galeotti F, Iannetti GD, Cruccu G.

Neurosci Lett. 2004 May 6;361(1-3):25-8. Review.

PMID:
15135884
11.

Narrative review: Fabry disease.

Clarke JT.

Ann Intern Med. 2007 Mar 20;146(6):425-33. Review.

PMID:
17371887
12.

Evaluation of peripheral and autonomic nerve function in Fabry disease.

Hilz MJ.

Acta Paediatr Suppl. 2002;91(439):38-42. Review.

PMID:
12572841
13.

[Fabry disease : diagnosis and treatment].

Üçeyler N, Sommer C.

Schmerz. 2012 Sep;26(5):609-19. doi: 10.1007/s00482-012-1238-1. Review. German.

PMID:
23052995
14.

Neurophysiological studies of thin myelinated (A delta) and unmyelinated (C) fibers: application to peripheral neuropathies.

Santiago S, Ferrer T, Espinosa ML.

Neurophysiol Clin. 2000 Feb;30(1):27-42. Review.

PMID:
10740794
15.

[Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature].

Riccio E, Capuano I, Visciano B, Marchetiello C, Petrillo F, Pisani A.

G Ital Nefrol. 2013 Sep-Oct;30(5). pii: gin/30.5.5. Review. Italian.

PMID:
24402625
16.

Fabry disease: a review of current management strategies.

Mehta A, Beck M, Eyskens F, Feliciani C, Kantola I, Ramaswami U, Rolfs A, Rivera A, Waldek S, Germain DP.

QJM. 2010 Sep;103(9):641-59. doi: 10.1093/qjmed/hcq117. Epub 2010 Jul 21. Review.

PMID:
20660166
17.

[Diagnostic and clinical aspects of neuropathy of small nerve fibers].

Strian F.

Fortschr Neurol Psychiatr. 1990 Feb;58(2):51-65. Review. German.

PMID:
2180799
18.

Pathophysiology and assessment of neuropathic pain in Fabry disease.

Schiffmann R, Scott LJ.

Acta Paediatr Suppl. 2002;91(439):48-52. Review.

PMID:
12572843
19.

Quantitative sensory testing: methodology, applications, and future directions.

Gruener G, Dyck PJ.

J Clin Neurophysiol. 1994 Nov;11(6):568-83. Review.

PMID:
7860720
20.

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C, Møller AT, Hilz MJ.

BMC Neurol. 2011 May 27;11:61. doi: 10.1186/1471-2377-11-61. Review.

Supplemental Content

Support Center